Watch for Changes to Varenicline and Bupropion Labeling

You'll hear about labeling changes for varenicline (Chantix) and bupropion for smoking cessation.

That's because new data suggest that these meds do NOT increase mood changes, agitation, nightmares, or other psychiatric side effects in patients quitting smoking.

In fact, these effects may be due to quitting smoking itself.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals